Maintaining the immunological balance in parasitic infections: A role for TGF-β?

Parasitology Today

Volumn 16, Issue 1, 2000, Pages 18-23

  Omer, Fakhereldin M ^a   Kurtzhals, Jørgen A L ^b   Riley, Eleanor M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

DISEASE SEVERITY; FEVER; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; MALARIA; NATURAL KILLER CELL; NONHUMAN; PARASITOSIS; PLASMODIUM FALCIPARUM; REVIEW;

ANIMALS; CHAGAS DISEASE; HOST-PARASITE RELATIONS; HUMANS; LEISHMANIASIS; MALARIA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLASMODIUM FALCIPARUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TRANSFORMING GROWTH FACTOR BETA; TRYPANOSOMA CRUZI; VARIATION (GENETICS);

MURINAE;

EID: 0033953639     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(99)01562-8     Document Type: Review

References (61)

1. 1 Fell, A.H. and Smith, N.C. (1998) Immunity to asexual blood stages of Plasmodium: is resistance to acute malaria adaptive or innate? Parasitol. Today 14, 364-369
2. 2 Riley, E.M. (1999) Is T cell priming required for initiation of pathology in malaria infections? Immunol. Today 20, 228-233
3. 3 Favre, N. et al. (1997) The course of Plasmodium chabaudi chabaudi infections in interferon-gamma receptor deficient mice. Parasite Immunol. 19, 375-383
4. 4 Shear, H.L. et al. (1989) Role of IFN-γ in lethal and nonlethal malaria in susceptible and resistant hosts. J. Immunol. 143, 2038-2044
5. 5 Jacobs, P. et al. (1996) A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice. Infect. Immun. 64, 535-541
6. 6 Waki, S. et al. (1992) The role of T cells in pathogenesis and protective immunity to murine malaria. Immunology 75, 646-651
7. 7 Kremsner, P.G. et al. (1992) Interferon-γ induced lethality in the late phase of Plasmodium vinckei malaria despite effective parasite clearance by chloroquine. Eur. J. Immunol. 22, 2873-2878
8. + cell-mediated pathology. Proc. Natl. Acad. Sci. U. S. A. 91, 8097-8101
9. 9 van der Heyde, H.C. et al. (1997) The time course of selected malarial infections in cytokine-deficient mice. Exp. Parasitol. 85, 206-213
10. 10 Linke, A. et al. (1996) Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. Exp. Parasitol. 84, 253-263
11. 11 de Kossodo, S. and Grau, G.E. (1993) Profiles of cytokine production in relation with susceptibility to cerebral malaria. J. Immunol. 151, 4811-4820
12. 12 Wahl, S.M. (1994) Transforming growth factor-β: the good, the bad and the ugly. J. Exp. Med. 180, 1587-1590
13. 13 Espevik, T. et al. (1987) Inhibition of cytokine production by cyclosporin A and transforming growth factor-β. J. Exp. Med. 166, 571
14. 14 Bellone, G. et al. (1995) Regulation of NK cell functions by TGF-β1. J. Immunol. 155, 1066-1073
15. 15 Nandan, D. and Reiner, N.E. (1997) TGF-β attenuates the class II transactivator and reveals an accessory pathway of IFN-γ action. J. Immunol. 158, 1095-1101
16. 16 Ruegemer, J.J. et al. (1990) Regulatory effects of transforming growth factor-β on IL-2-and IL-4-dependent T cell-cycle progression. J. Immunol. 144, 1767-1776
17. 17 Pardoux, C. et al. (1997) Functional interaction between TGF-β and IL-12 in human primary allogeneic cytotoxicity and proliferative response. J. Immunol. 158, 136-143
18. 18 Maeda, H. and Shiraishi, A. (1996) TGF-β contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J. Immunol. 156, 73-78
19. 19 Schull, M.M. et al. (1992) Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359, 693-699
20. 20 Stavnezer, J. (1995) Regulation of antibody production and class switching by TGF-β1. J. Immunol. 156, 1647-1651
21. 21 Omer, F.M. and Riley, E.M. (1998) TGF-beta production is inversely correlated with severity of murine malaria infection. J. Exp. Med. 188, 39-48
22. 22 Tsutsui, N. and Kamiyama, T. (1999) Transforming growth factor-β-induced failure of resistance to infection with blood-stage Plasmodium chabaudi in mice. Infect. Immun. 67, 2306-2311
23. 23 Wenisch, C. et al. (1995) Decreased serum levels of TGF-β in patients with acute Plasmodium falciparum malaria. J. Clin. Immunol. 15, 69-73
24. 24 Kurtzhals, J.A.L. et al. (1998) Low concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 351, 1768-1772
25. 25 Tsunawaki, S. et al. (1988) Deactivation of macrophages by transforming growth factor β. Nature 334, 260-262
26. 26 Nakabayashi, T. et al. (1997) Up-regulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-β1 knockout mice. J. Immunol. 158, 5527-5535
27. 27 Ockenhouse, C.F. et al. (1992) Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J. Exp. Med. 176, 1183-1189
28. 28 Ferrante, A. et al. (1990) Killing of Plasmodium falciparum by cytokine activated effector cells (neutrophils and macrophages). Immunol. Lett. 25, 179-187
29. 29 Welch, G.R. et al. (1998) Selective induction of FCγRIII on human monocytes by transforming growth factor-β. J. Immunol. 144, 3444-3448
30. 30 Snapper, C.M. et al. (1993) Transforming growth factor-β1 is required for secretion of IgG of all subclasses by LPS-activated murine B cells in vitro. J. Immunol. 151, 4625-4636
31. 31 Burns, J.M. et al. (1997) Protective immunity against Plasmodium yoelii malaria induced by immunisation with particulate blood stage antigens. Infect. Immun. 65, 3138-3145
32. 32 Miller, L.H. (1994) Impact of malaria on genetic polymorphism and genetic diseases in Africans and African Americans. Proc. Natl. Acad. Sci. U. S. A. 91, 2415-2419
33. 33 McGuire, W. et al. (1994) Variation in the TNFα promoter region associated with susceptibility to cerebral malaria. Nature 371, 508-511
34. 34 Awad, M.R. et al. (1997) Polymorphism in the TGF-β1 gene. Eur. J. Immunogenet. 24, 45
35. 35 Spaccapelo, R. et al. (1995) TGF-β is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. J. Immunol. 155, 1349-1360
36. 36 Sayles, P.C. et al. (1991) A spleen is not necessary to resolve infection with Plasmodium yoelii. Am. J. Trop. Med. Hyg. 44, 42-48
37. 37 Fitzpatrick, D.R. and Bielefeldt-Ohmann, H. (1999) Transforming growth factor β in infectious disease: always there for the host and the pathogen. Trends Microbiol. 7, 232-236
38. 38 Brunet, L.R. et al. (1998) Cytokine interaction and immune responses during Schistosoma mansoni infection. Parasitol. Today 14, 422-427
39. 39 Adewusi, O.I. et al. (1996) Production of TNFα by spleen cells of mice with chronic Schistosoma mansoni infections. Am. J. Trop. Med. Hyg. 55, A507
40. 40 Mwatha, J.K. et al. (1998) High levels of TNF, soluble TNF receptors, soluble ICAM-1 and IFNγ, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. J. Immunol. 160, 1992-1999
41. 41 Wynn, T.A. et al. (1997) Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1-and T helper cell 2-type cytokine responses in vivo. J. Immunol. 159, 5014-5023
42. 42 Williams, M.E. et al. (1995) Vaccination routes that fail to elicit protective immunity against Schistosoma mansoni induce the production of TGF-β, which down-regulates macrophage antiparasitic activity. J. Immunol. 154, 4693-4700
43. 43 Czaja, M.J. et al. (1989) In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J. Cell Biol. 108, 2477-2482
44. 44 Kingsley, D.M. (1994) The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8, 133-146
45. 45 Gomez-Escobar, N. et al. (1998) A novel member of the transforming growth factor-β (TGF-β) superfamily from the filarial nematodes Brugia malayia and B. pahangi. Exp. Parasitol. 88, 200-209
46. 46 Davies, S.J. et al. (1998) A divergent member of the transforming growth factor β receptor family from Schistosoma mansoni is expressed on the parasite surface membrane. J. Biol. Chem. 273, 11234-11240
47. 47 Ming, M. et al. (1995) Trypanosome invasion of mammalian cells requires activation of the TGF-β signalling pathway. Cell 82, 287-296
48. 48 Olsson, T. et al. (1993) CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule. Cell 72, 715-727
49. 49 Silva, J.S. et al. (1991) Regulation of Trypansoma cruzi infections in vitro by transforming growth factor β, TGF-β. J. Exp. Med. 174, 539-548
50. 50 Hunter, C.A. et al. (1997) IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J. Immunol. 158, 3311-3316
51. 51 Barral-Neto, M. et al. (1992) Transforming growth factor β in leishmanial infections: a parasite escape mechanism. Science 257, 545-548
52. 52 Rodrigues, V. et al. (1998) Transforming growth factor β and immunosuppression in experimental visceral leishmaniasis. Infect. Immun. 66, 1233-1236
53. 53 Barral, A. et al. (1995) Transforming growth factor-β in human cutaneous leishmaniasis. Am. J. Pathol. 147, 947-954
54. + T cell dependent interferon-gamma mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 184, 597-607
55. + cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 157, 798-805
56. 56 Hunter, C.A. et al. (1995) Transforming growth factor-β inhibits interleukin-12-induced production of IFN-γ by natural killer cells: a role for transforming growth factor-β in the regulation of T cell-independent resistance to Toxoplasma gondii. Eur. J. Immunol. 25, 994-1000
57. 57 Nunes, I. et al. (1998) Characterisation of latent TGF-β activation by murine peritoneal macrophages. J. Immunol. 155, 1450-1459
58. 58 Lawrence, D.A. (1991) Identification and activation of latent transforming growth factor β. Methods Enzymol. 198, 327-336
59. 59 Letterio, J.J. et al. (1994) Maternal rescue of transforming growth factor-β1 null mice. Science 264, 1936
60. 60 Weiner, H.L. (1997) Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today 18, 335-343
61. 61 Letterio, J.J. and Roberts, A.B. (1998) Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 137-161